Treco Douglas A

2.4

2.4

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

CRISPR Therapeutics AG (CRSP)

Transaction date 6 Aug 2025

Purchase

Price

236.77

Quantity 94,474 -21.2%

Value US$2,656,785

Comments Filing

Inozyme Pharma Inc (INZY)

Transaction date 2 Apr 2025

Sale

Price

443.55

Quantity 68,656 +6.4%

Value US$1,700,715

Comments Filing

Inozyme Pharma Inc (INZY)

Transaction date 2 Apr 2024

Sale

Price

110.57

Quantity 83,971 +45.9%

Value US$4,462,279

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-08-08	2025-08-06	CRISPR Therapeutics AG (CRSP)	B Purchase	94,474 -21.2% 236.77 US$2,656,785	94,474 -21.2%	236.77	US$2,656,785
2025-04-03	2025-04-02	Inozyme Pharma Inc (INZY)	S Sale	68,656 +6.4% 443.55 US$1,700,715	68,656 +6.4%	443.55	US$1,700,715
2024-04-03	2024-04-02	Inozyme Pharma Inc (INZY)	S Sale	83,971 +45.9% 110.57 US$4,462,279	83,971 +45.9%	110.57	US$4,462,279